/ALIF-B.ST

ALIF-B.ST Stock - AddLife AB (publ)

Q: What is the analyst price target for ALIF-B.ST?

Analyst price target information is not currently available for ALIF-B.ST.

Q: What is ALIF-B.ST's market cap?

Market capitalization information is not currently available for ALIF-B.ST.

Healthcare|Medical - Instruments & Supplies|STO

$162.30+1.12%

+$1.80 (+1.12%) • Dec 23

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $178.53

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for ALIF-B.ST

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.94

52W High$208.40

52W Low$130.10

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$10.29B	$9.69B	$9.08B	$7.99B	$5.27B
Gross Profit	$3.86B	$3.60B	$3.43B	$2.86B	$1.82B
Gross Margin	37.5%	37.2%	37.7%	35.7%	34.5%
Operating Income	$721.00M	$585.00M	$808.00M	$996.30M	$672.50M
Net Income	$252.00M	$190.00M	$480.00M	$719.00M	$517.80M
Net Margin	2.4%	2.0%	5.3%	9.0%	9.8%
EPS	$2.07	$1.56	$3.94	$6.02	$4.62

Company Overview

AddLife AB (publ), together with its subsidiaries, provides equipment, medical devices, and reagents primarily to healthcare system, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for haematology, pathology, point-of-care diagnostics, cell biology, genetics, microbiology, virology, molecular biology, clinical chemistry, immunology, consumables, and analytical instruments segments. This segment also offers support, maintenance, advice, and training services. The Medtech segment provides medical device products for surgery, respiration, intensive care, wound care, enteral nutrition, fall prevention, welfare technology, ear, and nose and throat segments, as well as bathroom-related assistive devices and assistive devices for children with disabilities. It operates in Sweden, Finland, Denmark, Norway, the United Kingdom, Ireland, Germany, Italy, Austria, Switzerland, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.

Visit Website

Earnings History & Surprises

ALIF-B.ST

Beat Rate

44%

Last 16 quarters

Avg Surprise

-3.8%

EPS vs Estimate

Beats / Misses

7/9

Last 12 quarters

Latest EPS

$0.67

Q4 2025

EPS Surprise History

Q1 24

-177.3%

$-0.34vs$0.44

Q2 24

-7.1%

$0.52vs$0.56

Q3 24

+13.2%

$0.60vs$0.53

Q4 24

-52.5%

$0.19vs$0.40

Q1 25

+16.9%

$0.76vs$0.65

Q2 25

+7.6%

$0.18vs$0.16

Q3 25

-16.6%

$0.82vs$0.98

Q4 25

-44.1%

$0.67vs$1.19

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	Apr 23, 2026	—	—	—	—
Q1 2026	Feb 4, 2026	—	—	—	—
Q4 2025	Oct 23, 2025	$1.19	$0.67	-44.1%	✗ MISS
Q3 2025	Jul 15, 2025	$0.98	$0.82	-16.6%	✗ MISS
Q2 2025	Apr 25, 2025	$0.16	$0.18	+7.6%	✓ BEAT
Q1 2025	Feb 5, 2025	$0.65	$0.76	+16.9%	✓ BEAT
Q4 2024	Oct 23, 2024	$0.40	$0.19	-52.5%	✗ MISS
Q3 2024	Jul 15, 2024	$0.53	$0.60	+13.2%	✓ BEAT
Q2 2024	Apr 24, 2024	$0.56	$0.52	-7.1%	✗ MISS
Q1 2024	Feb 2, 2024	$0.44	$-0.34	-177.3%	✗ MISS
Q4 2023	Oct 26, 2023	$0.24	$0.20	-16.7%	✗ MISS
Q3 2023	Jul 14, 2023	$0.56	$0.27	-51.8%	✗ MISS
Q2 2023	Apr 26, 2023	$0.51	$1.42	+178.4%	✓ BEAT
Q1 2023	Feb 2, 2023	$0.48	$0.50	+4.2%	✓ BEAT
Q4 2022	Oct 27, 2022	$0.47	$0.98	+108.5%	✓ BEAT
Q3 2022	Jul 15, 2022	$0.90	$0.62	-31.1%	✗ MISS
Q2 2022	Apr 28, 2022	$1.46	$1.84	+26.0%	✓ BEAT
Q1 2022	Feb 4, 2022	$1.78	$1.46	-18.0%	✗ MISS
Q4 2021	Oct 22, 2021	—	$1.13	—	—
Q3 2021	Jul 15, 2021	—	$1.46	—	—

Frequently Asked Questions about ALIF-B.ST

What is ALIF-B.ST's current stock price?

AddLife AB (publ) (ALIF-B.ST) is currently trading at $162.30 per share. The stock has moved +1.12% today.

What is the analyst price target for ALIF-B.ST?

No analyst price targets are currently available for this stock.

What sector is AddLife AB (publ) in?

AddLife AB (publ) operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the STO exchange.

What is ALIF-B.ST's market cap?

AddLife AB (publ) has a market capitalization of $19.04 billion, making it a large-cap company.

Does ALIF-B.ST pay dividends?

No, AddLife AB (publ) does not currently pay a dividend to shareholders.